Baird Capital
Baird Capital makes venture capital, growth equity, and private equity investments in strategically-targeted sectors around the world.
Business Model:
Revenue: $3.4B
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Baird Capital Information
Geographic Data
Address: 777 East Wisconsin Avenue
City: Milwaukee
State: WI
Zip: 53202
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$855M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
566,564Website Global Rank
79,478Website Monthly Traffic
Twitter Followers
Description
Baird Capital makes venture capital, growth equity, and private equity investments in strategically-targeted sectors around the world. The company values its creators who identify exceptional opportunities and partners with senior industry executives to build world-class companies. Its in-depth sector knowledge, deep relationships with entrepreneurial management teams, and global network of 60 investment and operating professionals in the United States, the United Kingdom, and Asia help ensure that the company consistently drives value in its portfolio companies. Baird Capital was founded on January 1, 1919 and is based in London, United Kingdom.
Contact Phone:
+18007922473
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2002 | Synarbor | Venture Round | - |
| 8/2013 | Keduo | Venture Round | - |
| 12/2005 | Pinstripe | Series A | 3M |
| 1/2013 | StartWire™ | Series B | 1.5M |
| 11/2020 | Upfront Healthcare Services | Series B | 0 |
| 6/2016 | Hireology | Series C | 12M |
| 5/2006 | Encover | Series C | 8M |
| 3/2020 | Aura Futures | Venture Round | - |
| 4/2015 | Alpha Source | Private Equity Round | - |
| 9/2016 | Datica | Series B | 6.5M |
| 12/2012 | ClickFuel | Series B | 4M |
| 5/2019 | AEGIS Hedging Solutions | Venture Round | 10.1M |
| 6/2002 | AIM Technology | Series A | 1.7M |
| 7/2017 | Amphora Medical | Series B | 35.5M |
| 1/2021 | Appdetex | Series C | 12.2M |
| 6/2004 | SmartTime Software | Venture Round | - |
| 5/2002 | Axcelerant | Series B | 0 |
| 11/2022 | Zylo | Series C | 31.5M |
| 2/2018 | Nirvana Asia | Venture Round | - |
| 12/2012 | Boston Plastics (Shanghai) Co., Ltd. | Private Equity Round | - |
| 3/2013 | Focaltech Systems | Private Equity Round | - |
| 7/2008 | Celleration | Series D | 0 |
| 9/2020 | Blue Matter | Private Equity Round | - |
| 4/2019 | Hireology | Series D | 27M |
| 8/2016 | FullContact | Series C | 25M |
| 1/2014 | Watkins Hire | Venture Round | 16.6M |
| 12/2022 | High Street Partners | Series B | 0 |
| 11/2022 | High Street Partners | Series B | 0 |
| 1/2003 | Everdream | Series D | 0 |
| 9/2012 | Edo Interactive | Series C | 15M |
| 6/2008 | Viant Medical | Venture Round | - |
| 4/2014 | Workforce Insight | Venture Round | - |
| 1/2022 | STR | Private Equity Round | - |
| 11/2013 | Sittercity | Series C | 0 |
| 9/2017 | Montage | Series D | 0 |
| 3/2012 | MI Bioresearch | Series A | 9.9M |
| 2/2004 | ArmorGroup International plc | Private Equity Round | 11.3M |
| 12/2012 | The SR Group | Venture Round | - |
| 6/2016 | Signal | Series E | 15M |
| 5/2014 | InsideTrack | Venture Round | 0 |
| 5/2014 | Appcast | Seed Round | 2.4M |
| 11/2001 | Apptimum | Venture Round | 7M |
| 5/2012 | Zurex Pharma | Series A | 6.2M |
| 4/2021 | Azzur Group, LLC | Venture Round | - |
| 6/2016 | Strata Oncology | Series A | 12M |
| 12/2020 | High Street Partners | Venture Round | - |
| 9/2006 | Caden Biosciences | Series A | 5.8M |
| 4/2011 | Sittercity | Series B | 22.6M |
| 3/2015 | Carsing | Series A | - |
| 4/2015 | Datica | Series B | 4M |
| 3/2012 | Wuhan Kindstar Diagnostics | Series C | 20M |
| 1/2016 | Arrive | Series C | 24M |
| 7/2021 | Saranas | Series B | 0 |
| 2/2018 | Collage Rehabilitation Partners | Private Equity Round | - |
| 7/2020 | Autobooks | Series A | 5.3M |
| 5/2010 | Arroweye Solutions | Private Equity Round | 8.4M |
| 7/2009 | ClickFuel | Series A | 2.5M |
| 9/2000 | Everdream | Series C | 0 |
| 4/2003 | Roche NimbleGen | Series D | 0 |
| 8/2015 | Synap Software Labs | Seed Round | 2M |
| 11/2017 | Hopebridge Autism Therapy Centers | Venture Round | 22.5M |
| 1/2011 | Celleration | Series E | 0 |
| 6/2013 | Veniti | Series B | 0 |
| 12/2013 | emids | Venture Round | 0 |
| 8/2013 | Kedu Healthcare Tech | Venture Round | - |
| 6/2013 | Edo Interactive | Venture Round | 7M |
| 8/2020 | eCube Solutions | Private Equity Round | - |
| 4/2020 | SourceDay | Series B | 12.5M |
| 9/2022 | Upfront Healthcare Services | Series C | 0 |
| 1/2015 | Apervita | Series A | 18M |
| 4/2008 | Frontage Laboratories | Private Equity Round | 10M |
| 8/2011 | High Street Partners | Series C | 0 |
| 11/2013 | Datica | Series A | 2.3M |
| 12/2013 | Sittercity | Debt Financing | 0 |
| 12/2006 | Campbell Alliance | Venture Round | 23M |
| 6/2018 | Zurex Pharma | Series D | 9M |
| 2/2011 | Coalfire | Series A | 5M |
| 3/2011 | Core Essence Orthopaedics | Series B | 11.5M |
| 2/2018 | Autobooks | Series A | 0 |
| 3/2013 | High Street Partners | Series D | 8M |
| 10/2018 | Crisp | Venture Round | 25M |
| 11/2004 | Roche NimbleGen | Series F | 12.8M |
| 7/2014 | WordStream | Series C | 9M |
| 7/2017 | Prescient Healthcare Group | Private Equity Round | - |
| 10/2007 | Encover | Series D | 2M |
| 3/2017 | Autobooks | Series A | 5.5M |
| 5/2020 | OncoHealth | Series C | 28M |
| 2/2008 | Snagajob | Series B | 5M |
| 4/2008 | CoAxia | Series C | 11.5M |
| 6/2014 | Montage | Series C | 0 |
| 10/2004 | CoAxia | Series B | 17.6M |
| 8/2009 | Palyon Medical | Series A | 24M |
| 4/2012 | Signal | Series C | 10M |
| 4/2008 | InsideTrack | Venture Round | 6.1M |
| 9/2010 | ADG | Venture Round | - |
| 11/2008 | Arroweye Solutions | Private Equity Round | 23.5M |
| 10/2011 | StartWire™ | Series A | 3.3M |
| 1/2017 | Elucent Medical | Series A | 7.2M |
| 3/2015 | Veniti | Series C | 0 |
| 3/2011 | Veniti | Series A | 0 |
| 2/2016 | Zaloni | Series A | 7.5M |
| 12/2016 | Integrated Diagnostics | Series C | 6.1M |
| 7/2014 | Zurex Pharma | Series B | 4.1M |
| 9/2013 | GenomeDx Biosciences | Series B | - |
| 1/2012 | GenomeDx Biosciences | Series A | - |
| 1/2015 | FullContact | Series B | 10M |
| 2/2004 | Austin Logistics | Series A | 0 |
| 3/2003 | NetRegulus | Series B | 0 |
| 5/2010 | High Street Partners | Series B | 6M |
| 5/2013 | SOLOMO | Series A | 1.7M |
| 10/2005 | Austin Logistics | Series B | 0 |
| 5/2015 | Edo Interactive | Series E | 20M |
| 6/2022 | Autobooks | Series C | 0 |
| 9/2021 | Vodori | Series A | 0 |
| 11/2021 | Virtual Incision | Series C | 0 |
| 12/2011 | Montage | Venture Round | 0 |
| 11/2018 | NeoChord | Series D | 25M |
| 1/2019 | Greenlight Biosciences | Venture Round | 50M |
| 10/2001 | Roche NimbleGen | Series B | 10.5M |
| 9/2006 | CoAxia | Series C | 11M |
| 1/2008 | Arbor Surgical Technologies | Series C | 0 |
| 4/2014 | Integrated Diagnostics | Series B | 31.7M |
| 5/2007 | Arroweye Solutions | Series C | 14M |
| 7/2006 | Snagajob | Series A | 9M |
| 8/2011 | Edo Interactive | Series B | 20M |
| 10/2013 | Insightra Medical | Series C | - |
| 7/2005 | Centerre Healthcare Corporation | Venture Round | 30M |
| 7/2008 | Accuri Cytometers | Series C | 13M |
| 4/2019 | ChurnZero | Series A | 0 |
| 6/2019 | NowSecure | Series B | 15M |
| 12/2014 | NowSecure | Series A | 12.5M |
| 5/2014 | Datica | Venture Round | 0 |
| 6/2009 | CoAxia | Series D | 21.5M |
| 9/2018 | Arrive | Series D | 20M |
| 3/2021 | ChurnZero | Series B | 25M |
| 10/2022 | Tellius | Series B | 0 |
| 11/2015 | Appcast | Series A | 0 |
| 5/2021 | Crayon | Series B | 0 |
| 1/2016 | ParkWhiz | Unattributed | 24M |
| 4/2022 | Quiq | Series C | 0 |
| 1/2021 | Jumpcode Genomics | Series B | 21M |
| 5/2018 | Strata Oncology | Series B | 26M |
| 6/2011 | Wuhan Kindstar Diagnostics | Series B | 11M |
| 11/2010 | PathCentral | Series B | 10M |
| 4/2007 | Accuri Cytometers | Series B | 5M |
| 4/2014 | NeuMoDx Molecular | Series B | 21M |
| 11/2021 | Circonus | Series B | 0 |
| 2/2022 | SourceDay | Series C | 0 |
| 7/2021 | Forj | Seed Round | - |
| 11/2019 | Apervita | Venture Round | 0 |
| 11/2013 | Signal | Series D | 27M |
| 6/2020 | Greenlight Biosciences | Series D | 102M |
| 5/2020 | Greenlight Biosciences | Venture Round | 0 |
| 7/2009 | Interlace Medical | Series C | 20.5M |
| 2/2013 | Coalfire | Series B | 3.6M |
| 12/2022 | Forj | Venture Round | 0 |
| 5/2019 | Cala Health | Series C | 0 |
| 10/2010 | Accuri Cytometers | Series E | 6M |
| 8/2009 | Accuri Cytometers | Series D | 4M |
| 3/2011 | Snagajob | Series C | 27M |
| 8/2017 | Housecall Pro | Series B | 11M |
| 11/2019 | AiCure | Series C | 24.5M |
| 6/2015 | NeoChord | Series C | 0 |
| 7/2021 | Strata Oncology | Series C | 0 |
| 12/2012 | Montage | Series B | 0 |
| 11/2017 | AiCure | Series B | 15M |
| 5/2011 | MI Bioresearch | Series A | 7M |
| 9/2010 | Montage | Series A | 0 |
| 6/1992 | AMSC | Post-IPO Equity | - |
| 1/2013 | Alpha Financial Markets Consulting | Venture Round | - |
| 6/2022 | Autobooks | Series C | 0 |
| 4/2022 | Quiq | Series C | 0 |
| 2/2022 | SourceDay | Series C | 0 |
| 1/2022 | STR | Private Equity Round | - |
| 11/2021 | Virtual Incision | Series C | 0 |
| 11/2021 | Circonus | Series B | 0 |
| 9/2021 | Vodori | Series A | 0 |
| 7/2021 | Strata Oncology | Series C | 0 |
| 7/2021 | Forj | Seed Round | - |
| 7/2021 | Saranas | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
